The thalidomide analog, EM 12, enhances 1,2-dimethylhydrazine-induction of rat colon adenocarcinomas

This publication has 12 references indexed in Scilit:

• SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
  The Lancet, 1988
• Teratogen metabolism: Spontaneous decay products of thalidomide and thalidomide analogues are not bioactivated by liver microsomes
  Teratogenesis, Carcinogenesis, and Mutagenesis, 1985
• Teratogen metabolism: Activation of thalidomide and thalidomide analogues to products that inhibit the attachment of cells to concanavalin a coated plastic surfaces
  Biochemical Pharmacology, 1984
• Inhibition of de Novo IgM Antibody Synthesis by Thalidomide as a Relevant Mechanism of Action in Leprosy
  Scandinavian Journal of Immunology, 1981
• Zusammentreffen einer Thalidomid-induzierten Fehlbildung mit einem malignen Lymphom hohen Malignitätsgrades
  Published by Springer Nature ,1980
• THALIDOMIDE-TYPE MALFORMATIONS AND SUBSEQUENT OSTEOSARCOMA
  The Lancet, 1977
• The teratogenic activity of α thalidomide analogue, EM12, in rabbits, rats, and monkeys
  Teratology, 1972
• Potentiating effect of thalidomide on methylcholanthrene oncogenesis in mice
  Cellular and Molecular Life Sciences, 1970
• Experimentelle Untersuchungen mit cyclischen Imiden bei Dimethylbenzanthracen-Tumoren der Sprague-Dawley-Ratte
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1967
• Thalidomide and Neoplasia
  Nature, 1963